These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 4611528)

  • 21. Correlation of acid alpha-glucosidase and glycogen content in skin fibroblasts with age of onset in Pompe disease.
    Umapathysivam K; Hopwood JJ; Meikle PJ
    Clin Chim Acta; 2005 Nov; 361(1-2):191-8. PubMed ID: 15993875
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Purification and properties of acid alpha-glucosidase (gamma-amylase) from the human liver].
    Belen'knĭ DM; Tsukerman DB; Rozenfel'd EL
    Biokhimiia; 1975; 40(5):927-33. PubMed ID: 1212451
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Type II glycogenosis].
    Joram A; Fessard C; Tron P; de Menibus CH; Dailly R
    Sem Hop; 1974 Feb; 50(7):489-95. PubMed ID: 4367932
    [No Abstract]   [Full Text] [Related]  

  • 24. Electrophysiological mechanism of the short PR interval in Pompe disease.
    Gillette PC; Nihill MR; Singer DB
    Am J Dis Child; 1974 Nov; 128(5):622-6. PubMed ID: 4529565
    [No Abstract]   [Full Text] [Related]  

  • 25. Enzyme therapy and prenatal diagnosis in glycogenosis type II.
    Hug G
    Am J Dis Child; 1974 Nov; 128(5):607-9. PubMed ID: 4278812
    [No Abstract]   [Full Text] [Related]  

  • 26. Branching enzyme-deficiency glycogenosis: studies in therapy.
    Fernandes J; Huijing F
    Arch Dis Child; 1968 Jun; 43(229):347-52. PubMed ID: 5240133
    [No Abstract]   [Full Text] [Related]  

  • 27. Glycogen storage diseases.
    Van Hoof F; Hue L; De Barsy T; Jacquemin P; Devos P; Hers HG
    Biochimie; 1972; 54(5):745-52. PubMed ID: 4347397
    [No Abstract]   [Full Text] [Related]  

  • 28. Biochemical genetics of the Lapland dog model of glycogen storage disease type II (acid alpha-glucosidase deficiency).
    Walvoort HC; Slee RG; Sluis KJ; Koster JF; Reuser AJ
    Am J Med Genet; 1984 Nov; 19(3):589-98. PubMed ID: 6391168
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Type 3 glycogenosis. A biochemical and electron microscopic study.
    Garancis JC; Panares RR; Good TA; Kuzma JF
    Lab Invest; 1970 May; 22(5):468-77. PubMed ID: 4316112
    [No Abstract]   [Full Text] [Related]  

  • 30. A fluorometric assay of alpha-glucosidase and its application in the study of Pompe's disease.
    Salafsky IS; Nadler HL
    J Lab Clin Med; 1973 Mar; 81(3):450-4. PubMed ID: 4265648
    [No Abstract]   [Full Text] [Related]  

  • 31. [Adult Pompe disease with normal acid alpha-glucosidase activity in leukocytes].
    Minato S; Kobayashi T; Tanaka K; Kitaguchi T; Goto I
    Rinsho Shinkeigaku; 1988 Apr; 28(4):413-6. PubMed ID: 3063423
    [No Abstract]   [Full Text] [Related]  

  • 32. Glycogen storage disease. Studies related to the mechanism of glycogenosome formation.
    Iwamasa T; Ninomiya N; Fukuda S; Hamada T; Hirashima M; Osame M
    Pathol Res Pract; 1983 Mar; 176(2-4):236-52. PubMed ID: 6304667
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complete correction of acid alpha-glucosidase deficiency in Pompe disease fibroblasts in vitro, and lysosomally targeted expression in neonatal rat cardiac and skeletal muscle.
    Pauly DF; Johns DC; Matelis LA; Lawrence JH; Byrne BJ; Kessler PD
    Gene Ther; 1998 Apr; 5(4):473-80. PubMed ID: 9614571
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tissue alpha-glucosidase activity and glycogen content in patients with generalized glycogenosis.
    Steinitz K; Rutenberg A
    Isr J Med Sci; 1967; 3(3):411-21. PubMed ID: 4951241
    [No Abstract]   [Full Text] [Related]  

  • 35. Replacement therapy for inherited enzyme deficiency. Use of purified glucocerebrosidase in Gaucher's disease.
    Brady RO; Pentchev PG; Gal AE; Hibbert SR; Dekaban AS
    N Engl J Med; 1974 Nov; 291(19):989-93. PubMed ID: 4415565
    [No Abstract]   [Full Text] [Related]  

  • 36. Hepatic glycogen storage disease. Clinical and laboratory findings in 23 cases.
    Spencer-Peet J; Norman ME; Lake BD; McNamara J; Patrick AD
    Q J Med; 1971 Jan; 40(157):95-114. PubMed ID: 5282941
    [No Abstract]   [Full Text] [Related]  

  • 37. Renal cortical tubular glycogen localization in glycogenosis type II (Pompe's disease).
    Witzleben CL
    Lab Invest; 1969 May; 20(5):424-9. PubMed ID: 4305720
    [No Abstract]   [Full Text] [Related]  

  • 38. Qualitative characteristics of the beta-glucosidase isozymes.
    Choy FY; Davidson RG
    Prog Clin Biol Res; 1982; 95():415-41. PubMed ID: 6812079
    [No Abstract]   [Full Text] [Related]  

  • 39. Replacing acid alpha-glucosidase in Pompe disease: recombinant and transgenic enzymes are equipotent, but neither completely clears glycogen from type II muscle fibers.
    Raben N; Fukuda T; Gilbert AL; de Jong D; Thurberg BL; Mattaliano RJ; Meikle P; Hopwood JJ; Nagashima K; Nagaraju K; Plotz PH
    Mol Ther; 2005 Jan; 11(1):48-56. PubMed ID: 15585405
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Glycogen metabolism and acid alpha-glucosidase in animals (author's transl)].
    Fujimori K
    Tanpakushitsu Kakusan Koso; 1973 Nov; 18(11):1018-34. PubMed ID: 4587671
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.